News

 

Derek Hill comments on Amyloid in Alzheimer's Disease Trials on BBC Radio4 Today show, Thursday 2nd February 2012

 

COMING UP:

IXICO will be attending the 7th Annual Biomarkers Congress 2012, on Tuesday 21st February in Manchester, UK

 

Email info@ixico.com for more details or to arrange a meeting.

 

 

ISO 9001 Certified

EVENTS

 

In 2012, IXICO will be attending:

 

The 6th Human Amyloid Imaging Meeting (HAI)

the Miami Beach Resort, Miami Beach, Florida. January 12-13, 2012

 

10th Annual Mild Cognitive Impairment Symposium

the Miami Beach Resort, Miami Beach, Florida. January 14-15, 2012

 

One Nucleus - Life Science Leadership Series: CNS and Ageing

Clare College, Cambridge. January 26, 2012

 

7th Annual Biomarkers Congress 2012

Manchester, UK. February 21-22, 2012 

 

27th International Conference of Alzheimer's Disease International

ExCel Centre, London. March 7-10, 2012

 

12th International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy

Stockholm, Sweden. May 9-12, 2012

 

Alzheimer's Association International Conference 12 (ICAD)

Vancouver Convention Center, Vancouver, British Columbia, Canada. July 14-19, 2012 


Third Biennial Conference on Resting State Brain Connectivity

Maritim Hotel, Magdeburg, Germany. September 5-7, 2012


5th Conference Clinical Trials on Alzheimer's Disease (CTAD)

Monaco. October 29-31, 2012 

 

 

In 2011, IXICO hosted:

Launch of the UCL Medical Imaging Informatics Platform

The Wellcome Collection, London, United Kingdom. June 28, 2011 from 1:30 PM - 6:30 PM (GMT)

         - A Summary of the UCL MIIP Launch event


 

For more information on an event or to arrange a meeting, please send an email to customer support

"Advanced imaging is key to testing new treatments for major disease, and for selecting the patients who will most benefit from those treatments.  IXICO's  quantitative imaging technology is widely used in clinical trials. We are now addressing the even more important challenge of making this technology available in the clinic."

Prof Derek Hill,
CEO & CSO, IXICO